BIOVERATIV INC. Net Income
BIOVERATIV INC. reported Net Income of $141.30 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2018-02-14
- BIOVERATIV INC. net income (loss) attributable to parent for the quarter ending 2017-12-31 was $141.30M, a 38.27% decline year-over-year.
- BIOVERATIV INC. net income (loss) attributable to parent for the quarter ending 2017-09-30 was $67.90M, a 15.65% decline year-over-year.
- BIOVERATIV INC. net income (loss) attributable to parent for the quarter ending 2017-06-30 was $77.10M, a 21.42% increase year-over-year.
- BIOVERATIV INC. net income (loss) attributable to parent for the quarter ending 2017-03-31 was $69.30M, a 3.90% increase year-over-year.
- BIOVERATIV INC. net income (loss) attributable to parent for fiscal 2017 was $355.60M, a 19.11% decline from fiscal 2016.
- BIOVERATIV INC. net income (loss) attributable to parent for fiscal 2016 was $439.60M, a 304.79% increase from fiscal 2015.
- BIOVERATIV INC. net income (loss) attributable to parent for fiscal 2015 was $108.60M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-12-31 | $141.30M 10-K · filed 2018-02-14 | $209.20M derived: sum of 2 quarters · filed 2018-02-14 | $286.30M derived: sum of 3 quarters · filed 2018-02-14 | $355.60M 10-K · filed 2018-02-14 |
| 2017-09-30 | $67.90M 10-K · filed 2018-02-14 | $145.00M derived: sum of 2 quarters · filed 2018-02-14 | $214.30M 10-Q · filed 2017-10-27 | $443.20M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $77.10M 10-K · filed 2018-02-14 | $146.40M 10-Q · filed 2017-08-03 | $375.30M derived: sum of 3 quarters · filed 2018-02-14 | $455.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $69.30M 10-K · filed 2018-02-14 | $298.20M derived: sum of 2 quarters · filed 2018-02-14 | $378.70M derived: sum of 3 quarters · filed 2018-02-14 | $442.20M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $228.90M 10-K · filed 2018-02-14 | $309.40M derived: sum of 2 quarters · filed 2018-02-14 | $372.90M derived: sum of 3 quarters · filed 2018-02-14 | $439.60M 10-K · filed 2018-02-14 |
| 2016-09-30 | $80.50M 10-K · filed 2018-02-14 | $144.00M derived: sum of 2 quarters · filed 2018-02-14 | $210.70M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $63.50M 10-K · filed 2018-02-14 | $130.20M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $66.70M 10-K · filed 2018-02-14 | |||
| 2015-12-31 | $108.60M 10-K · filed 2018-02-14 |